Introduction

Vitamin B12 (cobalamin) is essential for red blood cell production, nervous system integrity, and DNA synthesis. Deficiency is common in older adults, people with malabsorption, and those following strict plant-based diets. The clinical presentation can be gradual, making early recognition important to prevent long-term harm.

Key clinical consequences

B12 deficiency manifests across several organ systems. Hematologically, it often causes megaloblastic anemia characterized by fatigue, pallor, and shortness of breath. Neurologically, it can lead to paresthesia, impaired coordination, and gait disturbances caused by demyelination. Metabolically, low B12 raises homocysteine levels, which is associated with cardiovascular risk and may influence cognitive decline.

Neurological and nerve-related effects

Cobalamin supports myelin maintenance and neurotransmitter synthesis. When deficient, patients can experience numbness, tingling, reduced vibration sense, and balance problems. Severe or prolonged deficiency may cause subacute combined degeneration of the spinal cord, producing weakness, spasticity, and sensory ataxia. Early supplementation tends to yield better neurologic recovery, whereas long-standing damage can be only partially reversible.

Anemia and systemic symptoms

Inadequate B12 impairs DNA synthesis in erythroid precursors, producing large, immature red blood cells and anemia. Clinical signs include fatigue, decreased exercise tolerance, tachycardia, and dizziness. Laboratory evaluation typically shows macrocytosis on a complete blood count and low serum B12; methylmalonic acid (MMA) and homocysteine measurements can help confirm functional deficiency.

Metabolic and cognitive implications

B12-dependent reactions are central to methylation pathways. Disruption can elevate homocysteine and reduce S-adenosylmethionine (SAMe), interfering with neurotransmitter production and DNA methylation. Epidemiological and clinical studies link low B12 with cognitive impairment, increased brain atrophy, and higher rates of dementia in older adults. Some trials indicate cognitive benefits when deficiency is corrected early.

Risk groups and screening considerations

Groups at increased risk include older adults, individuals with pernicious anemia, those with gastrointestinal disorders (e.g., celiac disease, Crohn’s), post-bariatric surgery patients, and people on long-term metformin or proton pump inhibitors. Vegetarians and vegans are also at risk unless they consume fortified foods or supplements. Routine testing is reasonable for symptomatic individuals and high-risk populations.

Practical resources and further reading

For an overview of clinical outcomes and preventive strategies, see a concise review of the consequences of vitamin B12 deficiency. Broader discussions on supplementation trends and product purity are available in an analysis of why Europeans are choosing pure supplements, and foundational information on the nutrient can be found in an explanatory piece on is vitamin B12. A concise primer is also available at Is vitamin B12?

Maintaining awareness of risk factors, timely testing, and appropriate treatment are key to preventing irreversible outcomes. Clinical decisions about supplementation and route of administration should be guided by underlying cause and severity.